Most Shorted Biotech Stocks
Short interest as a percentage of float measures how heavily a stock is being bet against. Biotech is one of the most heavily shorted sectors because of its binary, event-driven nature. This ranking sorts biotech and pharma companies by short percent of float — the standard measure of short positioning — and shows days-to-cover (short ratio) as context.
Top 100 · data as of May 22, 2026.
- 1Monopar TherapeuticsMNPR · $636.6M67.1%9.0 days to cover
- 2LENZ Therapeutics, Inc.LENZ · $181.5M49.5%7.8 days to cover
- 3ARS Pharmaceuticals, Inc.SPRY · $788.5M41.5%15.7 days to cover
- 4Intellia Therapeutics, Inc.NTLA · $2.41B36.8%12.4 days to cover
- 5ImmunityBio, Inc.IBRX · $9.64B35.8%4.9 days to cover
- 6Rallybio CorpRLYB · $92.5M35.8%23.9 days to cover
- 7Replimune Group, Inc.REPL · $929.3M35.5%10.2 days to cover
- 8The Beauty Health CompanySKIN · $93.0M35.4%26.0 days to cover
- 9RECURSION PHARMACEUTICALS, INC.RXRX · $1.95B34.9%14.0 days to cover
- 10KalVista Pharmaceuticals, Inc.KALV · $1.44B31.9%3.2 days to cover
- 11Beam Therapeutics Inc.BEAM · $3.44B31.5%9.7 days to cover
- 12ABEONA THERAPEUTICS INC.ABEO · $344.8M31.1%16.9 days to cover
- 13Neuronetics Inc.STIM · $93.6M30.5%5.0 days to cover
- 14NOVAVAX INCNVAX · $1.56B30.3%15.6 days to cover
- 15SELLAS Life Sciences Group, Inc.SLS · $2.61B30.0%6.5 days to cover
- 16Pacira BioSciences, Inc.PCRX · $984.9M30.0%9.8 days to cover
- 17Neurogene Inc.NGNE · $535.4M29.8%22.6 days to cover
- 18Twist Bioscience CorpTWST · $6.37B28.7%11.0 days to cover
- 19Absci CorporationABSI · $1.88B28.6%8.7 days to cover
- 20IOVANCE BIOTHERAPEUTICS, INC.IOVA · $1.77B28.4%7.8 days to cover
- 21QuidelOrtho CorpQDEL · $1.24B28.4%5.7 days to cover
- 22Arcturus Therapeutics Holdings Inc.ARCT · $195.8M28.2%15.5 days to cover
- 23Sarepta Therapeutics, Inc.SRPT · $1.92B28.0%7.7 days to cover
- 24Sana Biotechnology, Inc.SANA · $990.7M27.8%11.5 days to cover
- 25Cardiff Oncology, Inc.CRDF · $88.2M27.5%25.5 days to cover
- 26Schrodinger, Inc.SDGR · $1.22B27.4%10.1 days to cover
- 27Tango Therapeutics, Inc.TNGX · $4.68B26.9%12.9 days to cover
- 28CRISPR Therapeutics AGCRSP · $5.48B26.7%12.9 days to cover
- 29Kodiak Sciences Inc.KOD · $2.33B26.5%5.4 days to cover
- 30Syndax Pharmaceuticals IncSNDX · $1.85B26.4%13.5 days to cover
- 31Candel Therapeutics, Inc.CADL · $723.9M26.1%8.9 days to cover
- 32Stoke Therapeutics, Inc.STOK · $2.04B25.8%13.3 days to cover
- 33HERON THERAPEUTICS, INC. /DE/HRTX · $80.3M25.7%19.9 days to cover
- 34Karyopharm Therapeutics Inc.KPTI · $219.4M25.5%3.4 days to cover
- 35Corvus Pharmaceuticals, Inc.CRVS · $1.24B24.9%14.9 days to cover
- 36Journey Medical CorpDERM · $193.8M24.5%17.6 days to cover
- 37Rocket Pharmaceuticals Inc.RCKT · $384.4M24.2%7.9 days to cover
- 38Biomea Fusion, Inc.BMEA · $98.3M24.2%7.2 days to cover
- 39Nuvation Bio Inc.NUVB · $1.89B24.1%15.1 days to cover
- 40TG THERAPEUTICS, INC.TGTX · $8.19B23.7%13.6 days to cover
- 414D Molecular Therapeutics, Inc.FDMT · $663.4M23.4%14.1 days to cover
- 42Legend Biotech CorpLEGN · $5.78B23.4%7.7 days to cover
- 43aTYR PHARMA INCATYR · $57.8M23.3%22.0 days to cover
- 44OMEROS CORPOMER · $681.1M22.7%11.7 days to cover
- 45XOMA Royalty CorporationXOMA · $753.5M22.6%12.8 days to cover
- 46Tectonic Therapeutic, Inc.TECX · $617.8M22.6%7.5 days to cover
- 47Zenas BioPharma, Inc.ZBIO · $1.77B22.5%11.6 days to cover
- 48Greenwich LifeSciences, Inc.GLSI · $347.9M22.5%11.6 days to cover
- 49Tyra Biosciences, Inc.TYRA · $1.75B22.4%6.2 days to cover
- 50Tenaya Therapeutics, Inc.TNYA · $161.9M22.2%4.5 days to cover
- 51Altimmune, Inc.ALT · $612.6M22.1%9.4 days to cover
- 52ANAPTYSBIO, INCANAB · $1.94B22.1%6.3 days to cover
- 53Immunovant, Inc.IMVT · $7.83B21.9%13.2 days to cover
- 54Viking Therapeutics, Inc.VKTX · $4.35B21.9%9.7 days to cover
- 55Inhibikase Therapeutics, Inc.IKT · $256.1M21.9%18.3 days to cover
- 56COLLEGIUM PHARMACEUTICAL, INCCOLL · $1.16B21.9%11.8 days to cover
- 57RIGEL PHARMACEUTICALS INCRIGL · $708.4M21.8%11.6 days to cover
- 58Xencor IncXNCR · $1.14B21.7%11.4 days to cover
- 59Rezolute, Inc.RZLT · $476.6M21.7%9.1 days to cover
- 60Summit Therapeutics Inc.SMMT · $11.16B21.6%7.6 days to cover
- 61Cabaletta Bio, Inc.CABA · $487.5M21.6%10.4 days to cover
- 62Avalo Therapeutics, Inc.AVTX · $908.9M21.5%7.3 days to cover
- 63Prime Medicine, Inc.PRME · $702.6M21.5%16.4 days to cover
- 64Oric Pharmaceuticals, Inc.ORIC · $1.13B21.5%9.2 days to cover
- 65ANAVEX LIFE SCIENCES CORP.AVXL · $239.1M21.4%18.4 days to cover
- 66MoonLake ImmunotherapeuticsMLTX · $1.60B21.2%8.4 days to cover
- 67Biohaven Ltd.BHVN · $2.37B21.1%12.4 days to cover
- 68Ocugen, Inc.OCGN · $501.0M21.0%7.4 days to cover
- 69CorMedix Inc.CRMD · $664.5M21.0%16.0 days to cover
- 70Humacyte Inc.HUMA · $181.4M20.9%4.5 days to cover
- 71CYTOKINETICS INCCYTK · $11.57B20.8%9.3 days to cover
- 72Monte Rosa Therapeutics, Inc.GLUE · $2.03B20.6%10.8 days to cover
- 73Cullinan Therapeutics, Inc.CGEM · $1.06B20.3%12.5 days to cover
- 74Compass Therapeutics, Inc.CMPX · $392.6M20.2%2.4 days to cover
- 75CAPRICOR THERAPEUTICS, INC.CAPR · $1.34B20.1%10.7 days to cover
- 76Verastem, Inc.VSTM · $360.3M20.1%8.4 days to cover
- 77Travere Therapeutics, Inc.TVTX · $5.24B20.0%5.4 days to cover
- 78Inhibrx Biosciences, Inc.INBX · $1.39B19.9%10.2 days to cover
- 79Apogee Therapeutics, Inc.APGE · $9.98B19.9%13.6 days to cover
- 80CRESCENT BIOPHARMA, INC.CBIO · $471.0M19.8%9.0 days to cover
- 81MADRIGAL PHARMACEUTICALS, INC.MDGL · $11.86B19.7%13.3 days to cover
- 82Immunocore Holdings plcIMCR · $1.61B19.6%19.7 days to cover
- 83Organogenesis Holdings Inc.ORGO · $314.0M19.4%7.5 days to cover
- 84Immuneering CorpIMRX · $326.7M19.4%12.4 days to cover
- 85C4 Therapeutics, Inc.CCCC · $479.9M19.2%7.1 days to cover
- 86Coherus Oncology, Inc.CHRS · $222.1M19.1%29.3 days to cover
- 87ANI PHARMACEUTICALS INCANIP · $1.89B19.0%10.8 days to cover
- 88Emergent BioSolutions Inc.EBS · $427.2M19.0%12.2 days to cover
- 89Bicara Therapeutics Inc.BCAX · $1.90B19.0%15.7 days to cover
- 90AbCellera Biologics Inc.ABCL · $2.32B18.9%8.8 days to cover
- 91Nurix Therapeutics, Inc.NRIX · $2.47B18.8%12.9 days to cover
- 92Gossamer Bio, Inc.GOSS · $82.0M18.2%3.6 days to cover
- 93Fortress Biotech Inc.FBIO · $102.6M18.1%10.4 days to cover
- 94Mirum Pharmaceuticals, Inc.MIRM · $7.35B18.1%11.5 days to cover
- 95Lexeo Therapeutics, Inc.LXEO · $349.4M18.0%13.1 days to cover
- 96Moderna, Inc.MRNA · $28.77B18.0%10.3 days to cover
- 97uniQure N.V.QURE · $3.11B18.0%6.2 days to cover
- 98SOLENO THERAPEUTICS INCSLNO · $2.76B17.9%1.0 days to cover
- 99INOVIO PHARMACEUTICALS, INC.INO · $97.9M17.9%4.9 days to cover
- 100Oruka Therapeutics, Inc.ORKA · $5.63B17.9%3.5 days to cover
Ranked by short interest as a percentage of float. Includes active companies with a market cap of at least $50.0M and reported short-interest data; companies without reported short interest are not shown.
Frequently asked questions
What does "short percent of float" mean?
It is the number of shares sold short divided by the freely tradable share float, expressed as a percentage. A higher value means a larger share of the float is held short.
What is days-to-cover (short ratio)?
Days-to-cover estimates how many days of average trading volume it would take short sellers to buy back (cover) all shorted shares. A higher ratio can amplify a short squeeze.
Why is biotech so heavily shorted?
Biotech valuations hinge on binary events — trial readouts, PDUFA decisions, cash runway — so both bulls and bears take large, opposing positions around those catalysts.